Nemeroff C B, Evans D L
Biol Psychiatry. 1983 Feb;18(2):237-41.
The therapeutic indications for propranolol have been steadily increasing in recent years. Propranolol and other beta-adrenergic blocking agents are now generally acknowledged to be helpful in the management of hypertension, certain cardiac arrhythmias, migraine, essential tremor, angina pectoris, and most recently, immediately after myocardial infarction (Frishman, 1981; Norwegian Multicenter Study Group, 1982). Because of the myriad clinical settings in which propranolol has been found to be of benefit, the interactions of these drugs with other commonly utilized pharmacological agents is of great pragmatic interest. In this report we describe the successful concomitant clinical use of propranolol and an antidepressant drug. This finding is also of interest because of recent theories concerning the mechanism of action of antidepressant drugs. Because propranolol readily penetrates into the CNS, it blocks beta-adrenergic receptors in both the periphery and the CNS (Weiner, 1980). Much attention has been focused recently on the effects of long-term antidepressant therapy on central beta-adrenergic receptors in the brain as a possible mechanism of action of these drugs. The concurrent use of propranolol and an antidepressant drug in the patient described in this report did not attenuate the therapeutic effects of the antidepressant.
近年来,普萘洛尔的治疗适应证一直在稳步增加。普萘洛尔和其他β-肾上腺素能阻滞剂目前普遍被认为有助于治疗高血压、某些心律失常、偏头痛、特发性震颤、心绞痛,以及最近发现的在心肌梗死后立即使用(弗里什曼,1981年;挪威多中心研究小组,1982年)。由于已发现普萘洛尔在众多临床情况下都有益处,这些药物与其他常用药物的相互作用具有很大的实际意义。在本报告中,我们描述了普萘洛尔与一种抗抑郁药成功的联合临床应用。由于最近有关抗抑郁药作用机制的理论,这一发现也很有意义。因为普萘洛尔很容易穿透进入中枢神经系统,它在外周和中枢神经系统中都能阻断β-肾上腺素能受体(韦纳,1980年)。最近,人们将大量注意力集中在长期抗抑郁治疗对大脑中枢β-肾上腺素能受体的影响上,将其作为这些药物可能的作用机制。在本报告所描述的患者中,普萘洛尔与抗抑郁药同时使用并未减弱抗抑郁药的治疗效果。